HomeClinical Trials
Finding and Understanding Clinical Trials
A clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.
This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results.
Find a Trial...
You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level.
Current Clinical Trial Listings:
Search results for Multiple Myeloma AND Recruiting
1)
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney FailureCancer-Related Problem/Condition; Multiple Myeloma and Plasma Cell Neoplasm
2)
Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
3)
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
4)
High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After ChemotherapyMultiple Myeloma and Plasma Cell Neoplasm
5)
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple MyelomaMultiple Myeloma
6)
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
7)
Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
8)
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple MyelomaMultiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
9)
This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple MyelomaRelapsed Multiple Myeloma; Refractory Multiple Myeloma; Multiple Myeloma
10)
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple MyelomaRelapse; Refractory Multiple Myeloma
11)
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I, Stage II, or Stage III Multiple MyelomaCancer-Related Problem/Condition; Multiple Myeloma and Plasma Cell Neoplasm
12)
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
13)
VEGF Trap in Treating Patients With Stage II or Stage III Multiple Myeloma That Has Relapsed or Not Responded to Previous TreatmentMultiple Myeloma and Plasma Cell Neoplasm
14)
Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Persistent Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
15)
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
16)
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
17)
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple MyelomaCancer-Related Problem/Condition; Multiple Myeloma and Plasma Cell Neoplasm
18)
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple MyelomaMultiple Myeloma
19)
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple MyelomaCancer-Related Problem/Condition; Multiple Myeloma and Plasma Cell Neoplasm
20)
Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm
